A Merus drug, combined with Keytruda, shows preliminary survival gains in newly diagnosed metastatic head and neck cancer ...

BMO Capital Markets reaffirmed its “Outperform” rating on Tourmaline Bio, Inc. (NASDAQ:TRML) with a price target of $35. The ...

Eikon Therapeutics, a Bay Area biotech startup with $1.1 billion in funding, is laying off dozens of employees and pointing ...

Volastra Therapeutics, a clinical-stage cancer biotechnology company focused on chromosomal instability, today announced preliminary safety and efficacy data from its ongoing, first-in-human Phase ...

Rapper Kid Cudi told a jury Sean "Diddy" Combs broke into his Los Angeles home after the hip-hop mogul found out he was ...

STAT reporters chat about the mood in the gene editing field, M&A deals in biotech, and leadership changes at Novo Nordisk.

The Beachwood-based company announced on Tuesday, May 20, that it has appointed Dr. David Llewellyn as its new CEO and as a ...

The Trump administration has revoked a $44 million dollar grant intended for the Birmingham area to bolster Biotechnology ...

A BioSpace survey found that 56% of employed and 81% of unemployed respondents are considering jobs outside biopharma. Some ...

Only three months after banking an eye-popping $350 million series D round, Eikon Therapeutics is blaming government funding ...

Trump’s tariffs and the global trade war continue to affect markets. Follow along for live updates on the Dow, S&P 500 and Nasdaq.

Viking Therapeutics has key trial catalysts ahead and trades near biotech deal valuations, despite dilution risks. Find out ...